These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25215120)

  • 1. Therapeutic effect of recombinant tissue plasminogen activator on acute cerebral infarction at different times.
    Liu M; Wang HR; Liu JF; Li HJ; Chen SX; Shen S; Pan SM
    World J Emerg Med; 2013; 4(3):205-9. PubMed ID: 25215120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early intravenous thrombolysis with recombinant tissue plasminogen activator for acute cerebral infarction].
    Wang SY; Wang XL; Zeng H; Zuo Y; Hu N; Li XY; Huang F; Yu HL; Wang HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):542-5. PubMed ID: 12971850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of intravenous thrombolysis with recombinant tissue type plasminogen activator (rt-PA) in different time windows on acute cerebral infarction patients with atrial fibrillation].
    Guo Y; Zhang CH; Wang HY; Lin YN; Wang Y; Sun XP
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(26):2054-8. PubMed ID: 27468616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Therapeutic Effect of Recombinant Tissue Plasminogen Activator by Treatment Time after Onset of Acute Ischemic Stroke.
    Wang HR; Chen M; Wang FL; Dai LH; Fei AH; Liu JF; Li HJ; Shen S; Liu M; Pan SM
    Sci Rep; 2015 Jul; 5():11743. PubMed ID: 26206308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of intravenous thrombolysis with rt-PA and urokinase for patients with acute cerebral infarction.
    Sun F; Liu H; Fu HX; Zhang S; Qian XD; Li JJ; Zhu YB; Zhang XX; Zhang J; Qiu HP; Kang LL; Hu YJ; Zhao L; Mi YJ; Gao YJ; Dou ZJ; Ma Z
    J Int Med Res; 2020 May; 48(5):300060519895352. PubMed ID: 32357116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of quantitative electroencephalogram monitoring in evaluating thrombolytic effect of acute cerebral infarction].
    Jin L; Wang Y; Lyu Z; Zhang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):207-210. PubMed ID: 33729141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study on the efficacy and safety of alteplase and urokinase in the treatment of acute cerebral infarction.
    Bao H; Gao HR; Pan ML; Zhao L; Sun HB
    Technol Health Care; 2021; 29(1):85-90. PubMed ID: 32925123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Clinical Efficacy of Recombinant Tissue Plasminogen Activator on Acute Cerebral Infarction.
    Wu T; Li P; Sun D
    J Nanosci Nanotechnol; 2020 Dec; 20(12):7781-7786. PubMed ID: 32711658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraarterial thrombolytic therapy within 3 hours of the onset of stroke.
    Bourekas EC; Slivka AP; Shah R; Sunshine J; Suarez JI
    Neurosurgery; 2004 Jan; 54(1):39-44; discussion 44-6. PubMed ID: 14683539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Study of Intravenous, Low-Dose Recombinant Tissue Plasminogen Activator for Acute Cerebral Infarction: Comparison of Treatment within 3 Hours versus 3-4.5 Hours.
    Deguchi I; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):1033-1040. PubMed ID: 29221968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of edaravone, the free radical scavenger, on outcomes in acute cerebral infarction patients treated with ultra-early thrombolysis of recombinant tissue plasminogen activator.
    Lee XR; Xiang GL
    Clin Neurol Neurosurg; 2018 Apr; 167():157-161. PubMed ID: 29501045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effect of mechanical fragmentation combined with recombinant tissue plasminogen activator artery thrombolysis on acute cerebral infarction.
    Jia XF; Hong Z; Fan JH; Zhang YM
    J Biol Regul Homeost Agents; 2016; 30(3):821-826. PubMed ID: 27655505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Effect of Butylphthalide Combined with Rt-PA Intravenous Thrombolysis in the Treatment of Acute Cerebral Infarction.
    Zhou X; Yang J; Liu L; Zhu Y
    Appl Bionics Biomech; 2022; 2022():9215685. PubMed ID: 35756870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimode Computed-Tomography-Guided Thrombolysis under a Prolonged Time Window in Acute Ischemic Stroke Patients with Atrial Fibrillation.
    Yang Y; Sun W; Li D; Li XY; Wang XT; Li SC; Zhao HJ; Zhang JB
    Int Heart J; 2019 Jul; 60(4):822-829. PubMed ID: 31257338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a modern stroke unit combined with recombinant human tissue-type plasminogen activator intravenous thrombolysis on ischemic cerebral infarction and its influence on limb motor function and activity of daily living.
    Wang Q; Hu M; Ye P
    Am J Transl Res; 2021; 13(8):9708-9714. PubMed ID: 34540099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.